Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

Jacksonville, Florida

Phase 1 cancer trials in Jacksonville, FL

47 Phase 1 cancer studies are recruiting participants at sites in Jacksonville as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Jacksonville at a glance

  • 47 studies are recruiting at a site in Jacksonville.
  • By phase: Early Phase 1 (1), Phase 1 (18), Phase 1/2 (28).
  • By sponsor: industry (42), university, hospital or other (5).
  • By research area: Lung Cancer (16), Breast Cancer (12), Lymphoma (9), Prostate Cancer (5), Pancreatic Cancer (4), Melanoma (1).
  • Most recent update to one of these records: November 17, 2026.

Breast cancer studies recruiting in Jacksonville

Basic details from each study's public record (the 30 most recently updated of 47). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    ORIC Pharmaceuticals
    Study site
    Mayo Clinic
    Registry record
    NCT05315700 · updated
  2. Phase 1 Study of CLR 125 in Triple Negative Breast Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Cellectar Biosciences, Inc.
    Study site
    Mayo Clinic Florida
    Registry record
    NCT07311993 · updated
  3. A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    AstraZeneca
    Registry record
    NCT05877599 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Jacksonville, FL on ClinicalTrials.gov.

Lung cancer studies recruiting in Jacksonville

  1. A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Study site
    Mayo Clinic Florida
    Registry record
    NCT07277413 · updated
  2. A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BlossomHill Therapeutics
    Study site
    Mayo Clinic - Florida
    Registry record
    NCT06706076 · updated
  3. A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kumquat Biosciences Inc.
    Study site
    Mayo Clinic, Jacksonville
    Registry record
    NCT06720987 · updated
  4. Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Synthekine
    Study site
    Mayo Jacksonville
    Registry record
    NCT05098132 · updated
  5. A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    AstraZeneca
    Registry record
    NCT06996782 · updated
  6. Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Study site
    Mayo Clinic Hospital Jacksonville /ID# 275073
    Registry record
    NCT06772623 · updated
  7. Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Tango Therapeutics, Inc.
    Study site
    Mayo Clinic Jacksonville
    Registry record
    NCT06922591 · updated
  8. Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Tango Therapeutics, Inc.
    Study site
    Mayo Clinic Jacksonville
    Registry record
    NCT06810544 · updated
  9. KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kura Oncology, Inc.
    Study site
    Mayo Clinic Comprehensive Cancer Center
    Registry record
    NCT06026410 · updated
  10. Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Exelixis
    Study site
    Exelixis Clinical Site #78
    Registry record
    NCT05176483 · updated
  11. A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Daiichi Sankyo
    Study site
    Mayo Clinic-Jacksonville
    Registry record
    NCT06362252 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Jacksonville, FL on ClinicalTrials.gov.

Prostate cancer studies recruiting in Jacksonville

  1. A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Regeneron Pharmaceuticals
    Study site
    Mayo Clinic Jacksonville
    Registry record
    NCT03972657 · updated
  2. Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

    • Phase 1
    • Ages 18 to 100
    • Male participants
    Sponsor
    Janux Therapeutics
    Study site
    Mayo Clinic
    Registry record
    NCT05519449 · updated
  3. Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients

    • Early Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Mayo Clinic
    Study site
    Mayo Clinic in Florida
    Registry record
    NCT05045066 · updated
  4. An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

    • Phase 1/2
    • Ages 18 and older
    • Male participants
    Sponsor
    Novartis Pharmaceuticals
    Study site
    Sarah Cannon Research Institute
    Registry record
    NCT07206056 · updated
  5. FOG-001 in Locally Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Parabilis Medicines, Inc.
    Study site
    Mayo Clinic
    Registry record
    NCT05919264 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Jacksonville, FL on ClinicalTrials.gov.

Melanoma studies recruiting in Jacksonville

  1. MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

    • Phase 1/2
    • Ages 18 to 90
    • All sexes
    Sponsor
    Perspective Therapeutics
    Study site
    Mayo Clinic
    Registry record
    NCT05655312 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Jacksonville, FL on ClinicalTrials.gov.

Lymphoma studies recruiting in Jacksonville

  1. The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

    • Phase 1/2
    • Up to age 22
    • All sexes
    Sponsor
    PedAL BCU, LLC
    Study site
    Nemours Children's Clinic-Jacksonville
    Registry record
    NCT04726241 · updated
  2. A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    AstraZeneca
    Registry record
    NCT07123454 · updated
  3. Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

    • Phase 1/2
    • Ages 13 to 90
    • All sexes
    Sponsor
    Vironexis Biotherapeutics Inc.
    Study site
    Mayo Clinic, Clinical Trials Referral Office
    Registry record
    NCT06533579 · updated
  4. A Study of APG-3288 in Relapsed/Refractory Blood Cancers

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Ascentage Pharma Group Inc.
    Study site
    Mayo Clinic
    Registry record
    NCT07424833 · updated
  5. CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Curis, Inc.
    Study site
    Mayo Clinic
    Registry record
    NCT03328078 · updated
  6. A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BeOne Medicines
    Study site
    Mayo Clinic Jacksonville
    Registry record
    NCT05006716 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Jacksonville, FL on ClinicalTrials.gov.

Pancreatic cancer studies recruiting in Jacksonville

  1. Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    RayzeBio, Inc.
    Registry record
    NCT07165132 · updated
  2. A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Artios Pharma Ltd
    Study site
    Mayo Clinic (Florida)
    Registry record
    NCT04657068 · updated
  3. Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    AstraZeneca
    Registry record
    NCT06005493 · updated
  4. Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    Mayo Clinic Cancer Center
    Registry record
    NCT06445062 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Jacksonville, FL on ClinicalTrials.gov.

Ask about studies near Jacksonville

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Florida

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call